ALEMBIC PHARMACEUTICALS
|
The Current P/E Ratio of ALEMBIC PHARMACEUTICALS is 24.55.
| Share Price | ₹1,050.6 | Nov 17,2026 |
| Market Cap | ₹20,653.8 Cr | |
| Earnings-TTM | ₹841.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 24.55x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALEMBIC PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹20,653.8 Cr] as on Nov 17,2026
(/) Earnings [ ₹841.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 24.55x ]
Thus, for ALEMBIC PHARMACEUTICALS , the investors are currently willing to pay 24.55 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALEMBIC PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALEMBIC PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of ALEMBIC PHARMACEUTICALS
PE Ratio Performance Analysis for ALEMBIC PHARMACEUTICALS
- ALEMBIC PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 27.68x.
- ALEMBIC PHARMACEUTICALS 's operated at median p/e ratio of 28.5x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALEMBIC PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 31.35x.
- ALEMBIC PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2026 of 19.28x.
How does ALEMBIC PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALEMBIC PHARMACEUTICALS | 841.46 | 24.55 | 20,653.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 40.65 | 448,688.0 |
| DIVIS LABORATORIES LTD | 3,363.00 | 87.38 | 293,874.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 84.65 | 177,677.0 |
| CIPLA LTD | 2,868.29 | 40.00 | 114,720.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 42.25 | 116,604.0 |
| MANKIND PHARMA LTD | 2,249.69 | 48.47 | 109,040.0 |
| LUPIN LTD | 5,221.47 | 17.24 | 90,038.7 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.85 | 119,970.0 |
| AUROBINDO PHARMA LTD | 3,993.05 | 25.95 | 103,626.0 |
| LAURUS LABS LTD | 1,333.75 | 94.07 | 125,460.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALEMBIC PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.24x |
| Max industry PE | 94.07x |
| Median industry PE | 40.65x |
| Average industry PE | 48.55x |
You may also like the below Video Courses